Legato Capital Management LLC Has $292,000 Stock Position in Doximity, Inc. (NASDAQ:DOCS)

Legato Capital Management LLC decreased its position in shares of Doximity, Inc. (NASDAQ:DOCS) by 18.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 5,465 shares of the company’s stock after selling 1,229 shares during the period. Legato Capital Management LLC’s holdings in Doximity were worth $292,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Louisiana State Employees Retirement System lifted its position in shares of Doximity by 2.6% in the fourth quarter. Louisiana State Employees Retirement System now owns 35,600 shares of the company’s stock worth $1,901,000 after buying an additional 900 shares during the last quarter. Shaker Investments LLC OH acquired a new stake in shares of Doximity in the fourth quarter worth about $559,000. Newbridge Financial Services Group Inc. acquired a new stake in shares of Doximity in the fourth quarter worth about $362,000. Entropy Technologies LP lifted its position in shares of Doximity by 162.2% in the fourth quarter. Entropy Technologies LP now owns 15,302 shares of the company’s stock worth $817,000 after buying an additional 9,467 shares during the last quarter. Finally, Empowered Funds LLC acquired a new stake in shares of Doximity in the fourth quarter worth about $3,009,000. Institutional investors and hedge funds own 87.19% of the company’s stock.

Insider Activity

In other news, Director Timothy S. Cabral sold 20,000 shares of the company’s stock in a transaction that occurred on Monday, February 3rd. The stock was sold at an average price of $57.62, for a total value of $1,152,400.00. Following the sale, the director now directly owns 6,360 shares in the company, valued at approximately $366,463.20. This represents a 75.87 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Corporate insiders own 37.40% of the company’s stock.

Wall Street Analyst Weigh In

DOCS has been the subject of a number of analyst reports. Barclays boosted their price target on Doximity from $52.00 to $75.00 and gave the stock an “overweight” rating in a research report on Monday, November 11th. JPMorgan Chase & Co. boosted their price objective on Doximity from $30.00 to $48.00 and gave the stock a “neutral” rating in a research report on Thursday, November 21st. Raymond James reissued an “outperform” rating and set a $83.00 price objective (up previously from $65.00) on shares of Doximity in a research report on Friday, February 7th. Piper Sandler raised Doximity from a “neutral” rating to an “overweight” rating and boosted their price objective for the stock from $31.00 to $78.00 in a research report on Friday, February 7th. Finally, The Goldman Sachs Group boosted their price objective on Doximity from $58.00 to $80.00 and gave the stock a “neutral” rating in a research report on Monday, February 10th. Eleven equities research analysts have rated the stock with a hold rating, eight have given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $64.22.

Doximity Stock Up 0.2 %

Shares of DOCS opened at $77.13 on Friday. Doximity, Inc. has a 12-month low of $22.96 and a 12-month high of $85.21. The firm has a market capitalization of $14.40 billion, a price-to-earnings ratio of 77.13, a P/E/G ratio of 4.61 and a beta of 1.39. The stock’s 50-day moving average price is $57.89 and its 200 day moving average price is $47.37.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.